153 related articles for article (PubMed ID: 12168745)
1. Pyogenic bacterial lower respiratory tract infection in human immunodeficiency virus-infected patients.
Mayaud C; Parrot A; Cadranel J
Eur Respir J Suppl; 2002 Jul; 36():28s-39s. PubMed ID: 12168745
[TBL] [Abstract][Full Text] [Related]
2. Risk factors in HIV-1-infected patients developing repetitive bacterial infections: toxicological, clinical, specific antibody class responses, opsonophagocytosis and Fc(gamma) RIIa polymorphism characteristics.
Payeras A; Martinez P; Milà J; Riera M; Pareja A; Casal J; Matamoros N
Clin Exp Immunol; 2002 Nov; 130(2):271-8. PubMed ID: 12390315
[TBL] [Abstract][Full Text] [Related]
3. Pneumonia in HIV-infected patients in the HAART era: incidence, risk, and impact of the pneumococcal vaccination.
López-Palomo C; Martín-Zamorano M; Benítez E; Fernández-Gutiérrez C; Guerrero F; Rodríguez-Iglesias M; Girón-González JA
J Med Virol; 2004 Apr; 72(4):517-24. PubMed ID: 14981752
[TBL] [Abstract][Full Text] [Related]
4. The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.
Losina E; Yazdanpanah Y; Deuffic-Burban S; Wang B; Wolf LL; Messou E; Gabillard D; Seyler C; Freedberg KA; Anglaret X
Antivir Ther; 2007; 12(4):543-51. PubMed ID: 17668563
[TBL] [Abstract][Full Text] [Related]
5. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
[TBL] [Abstract][Full Text] [Related]
6. Remission of relapsing Pseudomonas aeruginosa bronchopulmonary infection following antiretroviral therapy.
Domingo P; Ferré A; Baraldès MA; Ris J; Sánchez F
Arch Intern Med; 1998 Apr; 158(8):929-30. PubMed ID: 9570185
[No Abstract] [Full Text] [Related]
7. Discontinuation of secondary prophylaxis for Pneumocystis pneumonia in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy.
Esposito S; Bojanin J; Porta A; Cesati L; Gualtieri L; Principi N
Pediatr Infect Dis J; 2005 Dec; 24(12):1117-20. PubMed ID: 16371882
[TBL] [Abstract][Full Text] [Related]
8. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy.
Dankner WM; Lindsey JC; Levin MJ;
Pediatr Infect Dis J; 2001 Jan; 20(1):40-8. PubMed ID: 11176565
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
Lopez Bernaldo de Quiros JC; Miro JM; Peña JM; Podzamczer D; Alberdi JC; Martínez E; Cosin J; Claramonte X; Gonzalez J; Domingo P; Casado JL; Ribera E;
N Engl J Med; 2001 Jan; 344(3):159-67. PubMed ID: 11172138
[TBL] [Abstract][Full Text] [Related]
10. HIV infection and AIDS.
Lloyd A
P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
[TBL] [Abstract][Full Text] [Related]
11. [Bacterial pneumonia in HIV-infected patients (excluding mycobacterial infection)].
Godet C; Beraud G; Cadranel J
Rev Mal Respir; 2012 Oct; 29(8):1058-66. PubMed ID: 23101646
[TBL] [Abstract][Full Text] [Related]
12. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
[TBL] [Abstract][Full Text] [Related]
13. Coccidioidomycosis among persons with human immunodeficiency virus infection in the era of highly active antiretroviral therapy (HAART).
Ampel NM
Semin Respir Infect; 2001 Dec; 16(4):257-62. PubMed ID: 11740827
[TBL] [Abstract][Full Text] [Related]
14. Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: the Aquitaine Cohort, 1996-1997.
Binquet C; Chêne G; Jacqmin-Gadda H; Journot V; Savès M; Lacoste D; Dabis F;
Am J Epidemiol; 2001 Feb; 153(4):386-93. PubMed ID: 11207157
[TBL] [Abstract][Full Text] [Related]
15. [Severe bacterial infections after prophylactic suppression of Pneumocystis carinii in HIV infected patients after CD4 lymphocyte recovery].
Boix V; Murcia JM; Merino E; Portilla J
Med Clin (Barc); 2002 Jun; 118(20):796-7. PubMed ID: 12049699
[No Abstract] [Full Text] [Related]
16. [Immunologic findings in HIV infected children with bacterial infections].
Bunikowski R; Mielke M; Langhof M; Skarabis H; Schmitt M; Grosch-Wörner I
Klin Padiatr; 1996; 208(5):304-9. PubMed ID: 8992099
[TBL] [Abstract][Full Text] [Related]
17. Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Pulmonary Complications of HIV Infection Study Group.
Wallace JM; Hansen NI; Lavange L; Glassroth J; Browdy BL; Rosen MJ; Kvale PA; Mangura BT; Reichman LB; Hopewell PC
Am J Respir Crit Care Med; 1997 Jan; 155(1):72-80. PubMed ID: 9001292
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immune globulin for prevention of bacterial infections in pediatric AIDS patients.
Crow ME
Am J Health Syst Pharm; 1995 Apr; 52(8):803-11. PubMed ID: 7634115
[TBL] [Abstract][Full Text] [Related]
19. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS
Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
[TBL] [Abstract][Full Text] [Related]
20. Bacterial Respiratory Infections Complicating Human Immunodeficiency Virus.
Feldman C; Anderson R
Semin Respir Crit Care Med; 2016 Apr; 37(2):214-29. PubMed ID: 26974299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
